Literature DB >> 26786912

miRNA-Regulated Key Components of Cytokine Signaling Pathways and Inflammation in Rheumatoid Arthritis.

Ashish Ranjan Sharma1, Garima Sharma1, Sang-Soo Lee1, Chiranjib Chakraborty1,2.   

Abstract

Rheumatoid arthritis (RA) is an inflammatory disease that primarily affects joints. This autoimmune disease pathogenesis is related to cytokine signaling. In this review, we have described the existence of various microRNAs (miRNAs) involved in regulation of major protein cascades of cytokine signaling associated with RA. Moreover, we have tried to portray the role of various miRNAs in different cytokines such as TNF-α, IL-1, IL-6, IL-10, IL-17, IL-18, IL-21, and granulocyte macrophage colony-stimulating factor (GMCSF). Along with this, we have also discussed the miRNA regulation in T cells and synovial tissue. From the analyzed data, we suggest that miR-146a and miR-155 might be the potential therapeutic target for treating RA. The insight illustrated in this review will offer a better understanding of the role of miRNA in cytokine signaling pathways and inflammation during RA and could project them as diagnostic or therapeutic agents in near future.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  autoimmune disease; cytokine signaling; inflammation; microRNA; rheumatoid arthritis

Mesh:

Substances:

Year:  2016        PMID: 26786912     DOI: 10.1002/med.21384

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  20 in total

1.  MiR-663a/MiR-423-5p are involved in the pathogenesis of lupus nephritis via modulating the activation of NF-κB by targeting TNIP2.

Authors:  Weisong Wang; Junjie Gao; Fangli Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

2.  Role of miR-9-5p in preventing peripheral neuropathy in patients with rheumatoid arthritis by targeting REST/miR-132 pathway.

Authors:  Zunzhong Li; Yanshan Li; Qinghua Li; Zhenchun Zhang; Li Jiang; Xingfu Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-11-19       Impact factor: 2.416

3.  Identification of PBMC-expressed miRNAs for rheumatoid arthritis.

Authors:  Xiaowei Zhu; Longfei Wu; Xingbo Mo; Wei Xia; Yufan Guo; Mingjun Wang; Keqin Zeng; Jian Wu; Yinghua Qiu; Xiang Lin; Xin Lu; Feiyan Deng; Shufeng Lei
Journal:  Epigenetics       Date:  2019-10-10       Impact factor: 4.528

4.  Micro RNA-98 interferes with expression interleukin-10 in peripheral B cells of patients with lung cancer.

Authors:  Yun Li; Jian Rong; Jie Qin; Jin-Yuan He; Hui-Guo Chen; Shao-Hong Huang
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

Review 5.  The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Garima Sharma; Bimal Kumar Sarkar; Sang-Soo Lee
Journal:  Oncotarget       Date:  2018-01-23

Review 6.  The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis.

Authors:  Federico Biscetti; Andrea Flex; Stefano Alivernini; Barbara Tolusso; Elisa Gremese; Gianfranco Ferraccioli
Journal:  Mediators Inflamm       Date:  2017-10-23       Impact factor: 4.711

7.  Plasma miRNA-223 correlates with risk, inflammatory markers as well as prognosis in sepsis patients.

Authors:  Xiaoling Wu; Junhui Yang; Li Yu; Ding Long
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

8.  The small molecule NSM00191 specifically represses the TNF-α/NF-кB axis in foot and ankle rheumatoid arthritis.

Authors:  Xiaodong Wen; Xun Chen; Xiaojun Liang; Hongmou Zhao; Yi Li; Xiangxiang Sun; Jun Lu
Journal:  Int J Biol Sci       Date:  2018-10-03       Impact factor: 6.580

9.  Correlation of myomir-206 and proinflammatory cytokines (IL-16 and IL-17) in patients with rheumatoid arthritis.

Authors:  Amira Abo ElAtta; Yasser Ali; Iman Bassyouni; Roba Talaat
Journal:  Reumatologia       Date:  2019-04-29

10.  Correlation of microRNA expression profile with clinical response to tumor necrosis factor inhibitor in treating rheumatoid arthritis patients: A prospective cohort study.

Authors:  Yaqiong Liu; Yonghong Han; Huanru Qu; Jingpin Fang; Mei Ye; Wanling Yin
Journal:  J Clin Lab Anal       Date:  2019-06-27       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.